Navigation Links
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,

Human trials soon to begin which could lead to new treatments for millions of women suffering from fibroid tumors

Nashville, TN (Vocus) January 22, 2010 -- Researchers at Meharry Medical College have discovered that an extract of green tea could be used as a treatment for uterine fibroids, a disease that affects forty percent of reproductive age women.

An article published this week in the American Journal of Obstetrics and Gynecology, by Meharry’s Director of Clinical Research, Dr. Ayman Al-Hendy and his team of investigators, stated that an extract of green tea has the ability to kill human leiomyoma cells in tissue cultures and can eradicate fibroid lesions in animal models.

Al-Hendy said if the treatment is found to be effective in humans it can change the lives of millions of women who are currently faced with hysterectomy as their only treatment option.

“If we can prove this compound is effective, millions of women can start self treatment and self management,” he said.

The symptoms of uterine fibroids are often debilitating and include excessive vaginal bleeding, anemia, fatigue and lack of energy. According to Al-Hendy, women who suffer from uterine fibroids may lose time from work, have higher medical expenses and often need advanced medical treatment in order to become pregnant – all things that cause both emotional and economic hardship for families.

Al-Hendy and his team have conducted extensive research on the treatment of fibroid tumors and are dedicated to finding a cure for this disease which disproportionately affects African-American women who are four times more likely to be affected than women from other ethnic groups.

Researchers are in the process of recruiting participants for human trials that will begin soon.

The research will be conducted under the umbrella of the Meharry Clinical and Translational Research Center (MeTRC). In 2009, Meharry was awarded a $21.4 million grant from the National Center for Research Resources (NCRR) to establish MeTRC which will help accelerate the process of turning laboratory discoveries into actual cures and treatments used by patients.

MeTRC is a “center without walls” comprised of the Center for AIDS Health Disparities Research, the Center for Women’s Health Research and the Participant and Clinical Interactions Resource. Al-Hendy and Dr. James E.K. Hildreth serve as the principal investigators of this institutional grant.

About Meharry Medical College: Meharry Medical College is the nation’s largest private, independent, historically black academic health center dedicated solely to educating minority and other health professionals. True to its heritage, it is a United Methodist Church affiliated institution. The College is particularly well known for its uniquely nurturing, highly effective educational programs; emerging preeminence in health disparities research; culturally sensitive, evidence-based health services; and significant contribution to the diversity of the nation’s health professions workforce. Diverse Issues in Higher Education’s ranking of institutions annually lists Meharry as a leading national educator of African Americans with M.D. and D.D.S. degrees, and Ph.D. degrees in the biomedical sciences. Visit to learn more.

Janet M. Caldwell: 615.500.0632
Cynthia Yeldell: 615.327.6986 or 615.280.0319


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Researchers welcome new multiple sclerosis drug
2. Barrow researchers receive more than $2 million in NIH grants for nicotine studies
3. Researchers discover method to objectively identify PTSD
4. Researchers find a treatment for deadly brain tumor
5. Researchers find new insights into inherited retinal disease
6. Pitt researchers raise concern over frequency of surveillance colonoscopy
7. Stress triggers tumor formation, Yale researchers find
8. Johns Hopkins researchers say vaccine appears to mop up leukemia cells Gleevec leaves behind
9. St. Johns wort not helpful treatment for irritable bowel syndrome, Mayo Clinic researchers say
10. Young hunters most likely to be injured using tree stands, say UAB researchers
11. Researchers find clues to why some continue to eat when full
Post Your Comments:
Related Image:
Researchers at Meharry Medical College Find Green Tea Extract Showing Promise for Treatment of Uterine Fibroids,
(Date:6/27/2016)... ... June 27, 2016 , ... ... authorized OSHA Training Institute Education Center headquartered in Northern California, has issued an ... extreme heat at their worksites. Employers with workers exposed to high temperatures ...
(Date:6/27/2016)... ... June 27, 2016 , ... "FCPX editors can now reveal their media with ... X," said Christina Austin - CEO of Pixel Film Studios. , ProSlice Color ... users can now reveal the media of their split screens with growing colorful ...
(Date:6/27/2016)... ... June 27, 2016 , ... TherapySites, ... its affiliation with Tennessee Counseling Association. This new relationship allows TherapySites ... Tennessee Counseling Association, adding exclusive benefits and promotional offers. , "TCA is extremely ...
(Date:6/27/2016)... California (PRWEB) , ... June ... ... pioneer in the patient payment industry today announced its strategic partnership with ... health system workflows. , The two companies’ proven, proprietary technology combine to ...
(Date:6/27/2016)... ... June 27, 2016 , ... A ... revolutionize the emergency ambulance transport experience for the millions of people who require ... has disrupted the taxi industry through the use of technology. Now, SmartEMS has ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... BEVERLY HILLS, Calif. , June 23, 2016 ... faced the many challenges of the current process. Many of ... option because of the technical difficulties and high laboratory costs ... would have to offer it at such a high cost ... to afford it. Dr. Parsa Zadeh , ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
(Date:6/23/2016)... Research and Markets has announced the addition of ... their offering. The current ... environment for MedImmune to enter. The US ageing population creates ... drive considerable growth for effective anti-influenza medications. The introduction of ... but development is still in its infancy. ...
Breaking Medicine Technology: